Literature DB >> 8672567

Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.

M A Nalesnik1.   

Abstract

Posttransplant lymphoproliferative disorders (PTLDs) are a family of lymphoid hyperplasias and neoplasias that occur in the context of organ transplantation and immunosuppression. A strong association exists with Epstein-Barr virus (EBV) infection of the B lymphocyte. This review summarizes clinical and pathological aspects of these lesions and explains the terminology used to describe them. Clinical diagnosis and therapy, including experimental approaches, are outlined. Patient outcomes from published series are given. The clinical heterogeneity and the need to individualize therapy for these patients are stressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672567

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  16 in total

1.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.

Authors:  Sabine Köpf; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2004-02-12       Impact factor: 3.714

3.  Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy.

Authors:  Qian Tao; Jie Yang; He Huang; Lode J Swinnen; Richard F Ambinder
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Posttransplantation lymphoproliferative disorder of the paranasal sinuses mimicking invasive fungal sinusitis: case report.

Authors:  Andrew R Gordon; Laurie A Loevner; Adina I Sonners; William E Bolger; Mariusz A Wasik
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.

Authors:  Deirdre O'Mahony; John C Morris; Maryalice Stetler-Stevenson; Helen Matthews; Margaret R Brown; Thomas Fleisher; Stefania Pittaluga; Mark Raffeld; Paul S Albert; Dirk Reitsma; Karen Kaucic; Luz Hammershaimb; Thomas A Waldmann; John E Janik
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

6.  Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood.

Authors:  Massimiliano Bergallo; Chiara Merlino; Roberta Daniele; Franca Sinesi; Mara Fumagalli; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

7.  Posttransplant lymphoproliferative disease presenting as jejunal perforation.

Authors:  K C Krishna; G Sivaramakrishna; P M Kumar; T Kannan; K M Reddy; V Sivakumar
Journal:  Indian J Nephrol       Date:  2009-04

Review 8.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

Review 9.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Post-transplant lymphoproliferative disorders.

Authors:  K J Lewin
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.